trending Market Intelligence /marketintelligence/en/news-insights/trending/nihpnhou5rvaqhkx9pwc3q2 content esgSubNav
In This List

Biohaven Pharmaceutical director resigns

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Insight Weekly: Labor market struggles; solar demand remains strong; banks' deposit holdings


Biohaven Pharmaceutical director resigns

Biohaven Pharmaceutical Holding Co. Ltd. said Albert Cha notified the company of his intent to step down as the company's director, effective Sept. 7.

The company said Cha's resignation was not a result of any disagreement with the company or the board.

New Haven, Conn.-based Biohaven Pharmaceutical is a clinical-stage biopharmaceutical company that develops product candidates to treat neurological diseases, including rare disorders.